Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. |
avr. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. |
oct. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer |
oct. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer |
nov. 15 |
4 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database. |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. |
oct. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of Hepatology |
Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma |
juin. 18 |
5 ♥ |
Foie, Carcinome hépatocellulaire (CHC) |
Journal of Hepatology |
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B |
nov. 15 |
1 ♥ |
Foie |
Journal of Hepatology |
Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. |
déc. 16 |
4 ♥ |
Foie |
Journal of Hepatology |
Factors associated with spontaneous clearance of chronic hepatitis C virus infection |
aoû. 16 |
4 ♥ |
Foie |